Trials / Conditions / Translocation Renal Cell Carcinoma
Translocation Renal Cell Carcinoma
5 registered clinical trials studyying Translocation Renal Cell Carcinoma — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma NCT07123090 | Stephanie Berg | Phase 2 |
| Recruiting | A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC) NCT06835972 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma NCT06318871 | Dana-Farber Cancer Institute | EARLY_Phase 1 |
| Recruiting | Agnostic Therapy in Rare Solid Tumors NCT06638931 | Instituto do Cancer do Estado de São Paulo | Phase 2 |
| Active Not Recruiting | Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC NCT04413123 | Bradley A. McGregor, MD | Phase 2 |